Laboratory Animal and Comparative Medicine ›› 2022, Vol. 42 ›› Issue (4): 284-293.DOI: 10.12300/j.issn.1674-5817.2021.147
• Animal Experimental Techniques and Methods • Previous Articles Next Articles
Yiru WANG1(
)(
), Xiaoying JIANG1, Ruoxi DONG1, Yibin PAN1, Xianghui HAN2, Yongqing CAO1(
)(
)
Received:2021-09-02
Revised:2022-03-20
Online:2022-08-25
Published:2022-08-25
Correspondence to:
Yongqing CAO
CLC Number:
Yiru WANG,Xiaoying JIANG,Ruoxi DONG,et al. Modified Method for Inducing Acute Intestinal Fibrosis in Rats Using 2,4,6-Trinitrobenzene Sulfonic Acid[J]. Laboratory Animal and Comparative Medicine, 2022, 42(4): 284-293. DOI: 10.12300/j.issn.1674-5817.2021.147.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.slarc.org.cn/dwyx/EN/10.12300/j.issn.1674-5817.2021.147
Figure 2 Changes in rat body mass (A) and disease activity index (B) after model establishment
Figure 3 Colonic tissue of rats after model establishment
Figure 4 The length of rat colon after model establishment (A) and colon macroscopic damage index (B) in rats after model establishment
Figure 5 HE staining (A) and Masson staining (B) of rats’ colons after model establishment (×100)
| 1 | RIEDER F, BETTENWORTH D, MA C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease[J]. Aliment Pharmacol Ther, 2018, 48(3):347-357. DOI:10.1111/apt.14853 . |
| 2 | SCHMOYER C J, SAIDMAN J, BOHL J L, et al. The pathogenesis and clinical management of stricturing crohn disease[J]. Inflamm Bowel Dis, 2021, 27(11):1839-1852. DOI:10.1093/ibd/izab038 . |
| 3 | ROGLER G, HAUSMANN M. Factors promoting development of fibrosis in Crohn's disease[J]. Front Med (Lausanne), 2017, 4:96. DOI:10.3389/fmed.2017.00096 . |
| 4 | KUEMMERLE J F. Murine trinitrobenzoic acid-induced colitis as a model of Crohn's disease[J]. Methods Mol Biol, 2016, 1422:243-252. DOI:10.1007/978-1-4939-3603-8_22 . |
| 5 | MORRIS G P, BECK P L, HERRIDGE M S, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon[J]. Gastroenterology, 1989, 96(2):795-803. DOI:10.1016/S0016-5085(89)80079-4 . |
| 6 | MURANO M, MAEMURA K, HIRATA I, et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis[J]. Clin Exp Immunol, 2000, 120(1):51-58. DOI:10.1046/j.1365-2249.2000.01183.x . |
| 7 | BUTZNER J D, PARMAR R, BELL C J, et al. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat[J]. Gut, 1996, 38(4):568-573. DOI:10.1136/gut.38.4.568 . |
| 8 | RIEDER F, KESSLER S, SANS M, et al. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 303(7): G786-G801. DOI:10.1152/ajpgi.00059.2012 . |
| 9 | DE SALVO C, RAY S, PIZARRO T T. Mechanisms and models for intestinal fibrosis in IBD[J]. Dig Dis, 2014, 32():26-34. DOI:10.1159/000367822 . |
| 10 | ELSON C O, SARTOR R B, TENNYSON G S, et al. Experimental models of inflammatory bowel disease[J]. Gastroenterology, 1995, 109(4):1344-1367. DOI:10.1016/0016-5085(95)90599-5 . |
| 11 | 甘华田. 正确选择炎症性肠病实验研究的动物模型[J]. 胃肠病学, 2007, 12(3):132-134. |
| GAN H T. Select the correct animal model for experimental study of inflammatory bowel disease[J]. Chin J Gastroenterol, 2007, 12(3):132-134. | |
| 12 | ALFREDSSON J, WICK M J. Mechanism of fibrosis and stricture formation in Crohn's disease[J]. Scand J Immunol, 2020, 92(6): e12990. DOI:10.1111/sji.12990 . |
| 13 | 刘登瑞, 哈小琴, 高明太. 炎症性肠病动物模型的研究进展[J]. 中国比较医学杂志, 2008, 18(1):77-80. DOI:10.3969/j.issn.1008-7125.2009.09.012 . |
| LIU D R, HA X Q, GAO M T. Progress on animal model of inflammatory bowel disease[J]. Chin J Comp Med, 2008, 18(1):77-80. DOI:10.3969/j.issn.1008-7125.2009.09.012 . | |
| 14 | LI C, FLYNN R S, GRIDER J R, et al. Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide[J]. Inflamm Bowel Dis, 2013, 19(13):2829-2839. DOI:10.1097/MIB.0b013e3182a8452e . |
| 15 | LAWRANCE I C, WU F, LEITE A Z A, et al. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-κB[J]. Gastroenterology, 2003, 125(6):1750-1761. DOI:10.1053/j.gastro.2003.08.027 . |
| 16 | D'ALESSIO S, UNGARO F, NOVIELLO D, et al. Revisiting fibrosis in inflammatory bowel disease: the gut thickens[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(3):169-184. DOI:10.1038/s41575-021-00543-0 . |
| 17 | ZIDAR N, LANGNER C, JERALA M, et al. Pathology of fibrosis in Crohn's disease-contribution to understanding its pathogenesis[J]. Front Med (Lausanne), 2020, 7:167. DOI:10.3389/fmed.2020.00167 . |
| 18 | 方磊, 乔立超, 顾一帆, 等. 克罗恩病大小鼠动物模型研究进展[J]. 中国实验动物学报, 2020, 28(5):688-694. |
| FANG L, QIAO L C, GU Y F, et al. Progress on animal model of Crohn's disease in rats and mice[J]. Acta Lab Animalis Sci Sin, 2020, 28(5):688-694.[知网] | |
| 19 | SARTOR R B. Microbial influences in inflammatory bowel diseases[J]. Gastroenterology, 2008, 134(2):577-594. DOI:10.1053/j.gastro.2007.11.059 . |
| 20 | SCHEIFFELE F, FUSS I J. Induction of TNBS colitis in mice[J]. Curr Protoc Immunol, 2002, Chapter 15: Unit 15.19. DOI:10.1002/0471142735.im1519s49 . |
| 21 | 李球, 丁健. 小鼠灌肠方法的总结与优化[J]. 实验动物科学, 2020, 37(2):70-72. DOI:10.3969/j.issn.1006-6179.2020.02.012 . |
| LI Q, DING J. The summary and improvement of mice's Enema method[J]. Lab Animal Sci, 2020, 37(2):70-72. DOI:10.3969/j.issn.1006-6179.2020.02.012 . |
| [1] | ZHAO Xin, WANG Chenxi, SHI Wenqing, LOU Yuefen. Advances in the Application of Zebrafish in the Research of Inflammatory Bowel Disease Mechanisms and Drug Development [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 422-431. |
| [2] | WU Zhihao, CAO Shuyang, ZHOU Zhengyu. Establishment of an Intestinal Fibrosis Model Associated with Inflammatory Bowel Disease in VDR-/- Mice Induced by Helicobacter hepaticus Infection and Mechanism Exploration [J]. Laboratory Animal and Comparative Medicine, 2025, 45(1): 37-46. |
| [3] | Xiaorui ZHANG, Jing CAO, Qianqian WU, Jijun LIU, Guoyuan CHEN, Baojin WU. Effects of Probucol Formulations on Mesenteric Lymphatic Trans-port Efficiency and Pharmacokinetics in Rats [J]. Laboratory Animal and Comparative Medicine, 2022, 42(4): 275-283. |
| [4] | Sijia ZHAO, Xinyu HE, Quan JING, Lin MA, Chunlan GUO, Kuo WAN. Evaluation of Pain in Acute Pulpitis Hyperalgesia Model Rats [J]. Laboratory Animal and Comparative Medicine, 2022, 42(4): 333-341. |
| [5] | Xiaorui ZHANG, Jing CAO, Qianqian WU, Kang KANG, Guoyuan CHEN, Baojin WU. A Preliminary Method for Continuous Drainage of Mesenteric Lymph Fluid in Rats [J]. Laboratory Animal and Comparative Medicine, 2022, 42(4): 267-274. |
| [6] | Dingshan FENG, Yeyu HUANG, Xiaoxin ZHANG, Aiqin WU, Zhan WANG, Linliang SU. Effects of Storage Time on Electrolyte Content and pH Value in Rat Serum Samples [J]. Laboratory Animal and Comparative Medicine, 2022, 42(4): 301-305. |
| [7] | ZHOU Yani, LIU Dan. Therapeutic Effect of Anti-complement 5a Receptor Antibody Combined with Allicin on Induced Inflammatory Bowel Disease In Rats [J]. Laboratory Animal and Comparative Medicine, 2020, 40(4): 328-. |
| [8] | YUAN Xiao-hong, HE Feng, JIANG Ze-hui, ZHAO He, YE Chao, WU Shao-ming, YU Hai-chuan, LI Chun-gen. Establishment and Evaluation of Rat Model of Neurogenic Bladder after Spinal Cord Transection Injury [J]. Laboratory Animal and Comparative Medicine, 2016, 36(6): 423-427. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||